Logo image of MCFT

MASTERCRAFT BOAT HOLDINGS IN (MCFT) Stock Fundamental Analysis

NASDAQ:MCFT - Nasdaq - US57637H1032 - Common Stock - Currency: USD

19.36  -0.28 (-1.43%)

After market: 19.36 0 (0%)

Fundamental Rating

4

Taking everything into account, MCFT scores 4 out of 10 in our fundamental rating. MCFT was compared to 31 industry peers in the Leisure Products industry. While MCFT has a great health rating, its profitability is only average at the moment. MCFT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MCFT was profitable.
MCFT had a positive operating cash flow in the past year.
MCFT had positive earnings in 4 of the past 5 years.
In the past 5 years MCFT always reported a positive cash flow from operatings.
MCFT Yearly Net Income VS EBIT VS OCF VS FCFMCFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a Return On Assets value of -2.55%, MCFT perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
The Return On Equity of MCFT (-3.67%) is comparable to the rest of the industry.
The Return On Invested Capital of MCFT (1.55%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for MCFT is significantly above the industry average of 7.91%.
The 3 year average ROIC (30.44%) for MCFT is well above the current ROIC(1.55%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.55%
ROE -3.67%
ROIC 1.55%
ROA(3y)13.84%
ROA(5y)10.06%
ROE(3y)26.89%
ROE(5y)16.74%
ROIC(3y)30.44%
ROIC(5y)27.79%
MCFT Yearly ROA, ROE, ROICMCFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

MCFT's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.35%, MCFT perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
In the last couple of years the Operating Margin of MCFT has declined.
The Gross Margin of MCFT (17.16%) is worse than 83.87% of its industry peers.
MCFT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 17.16%
OM growth 3Y-32.32%
OM growth 5Y-17.63%
PM growth 3Y-43.91%
PM growth 5Y-14.25%
GM growth 3Y-11.99%
GM growth 5Y-5.47%
MCFT Yearly Profit, Operating, Gross MarginsMCFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MCFT is creating value.
The number of shares outstanding for MCFT has been reduced compared to 1 year ago.
Compared to 5 years ago, MCFT has less shares outstanding
MCFT has a worse debt/assets ratio than last year.
MCFT Yearly Shares OutstandingMCFT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MCFT Yearly Total Debt VS Total AssetsMCFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MCFT has an Altman-Z score of 4.42. This indicates that MCFT is financially healthy and has little risk of bankruptcy at the moment.
MCFT has a Altman-Z score of 4.42. This is in the better half of the industry: MCFT outperforms 77.42% of its industry peers.
MCFT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACC0.18
WACC8.73%
MCFT Yearly LT Debt VS Equity VS FCFMCFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

MCFT has a Current Ratio of 1.81. This is a normal value and indicates that MCFT is financially healthy and should not expect problems in meeting its short term obligations.
MCFT has a Current ratio of 1.81. This is in the lower half of the industry: MCFT underperforms 64.52% of its industry peers.
A Quick Ratio of 1.23 indicates that MCFT should not have too much problems paying its short term obligations.
MCFT has a worse Quick ratio (1.23) than 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.23
MCFT Yearly Current Assets VS Current LiabilitesMCFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

3. Growth

3.1 Past

MCFT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.40%.
MCFT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.07% yearly.
Looking at the last year, MCFT shows a very negative growth in Revenue. The Revenue has decreased by -41.66% in the last year.
MCFT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.70% yearly.
EPS 1Y (TTM)-81.4%
EPS 3Y-29.37%
EPS 5Y-16.07%
EPS Q2Q%-18.92%
Revenue 1Y (TTM)-41.66%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.7%
Sales Q2Q%-20.63%

3.2 Future

MCFT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.37% yearly.
The Revenue is expected to decrease by -3.04% on average over the next years.
EPS Next Y-38.68%
EPS Next 2Y1.64%
EPS Next 3Y7.37%
EPS Next 5YN/A
Revenue Next Year-24.1%
Revenue Next 2Y-6.16%
Revenue Next 3Y-3.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCFT Yearly Revenue VS EstimatesMCFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
MCFT Yearly EPS VS EstimatesMCFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 40.33, which means the current valuation is very expensive for MCFT.
MCFT's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MCFT to the average of the S&P500 Index (27.54), we can say MCFT is valued slightly more expensively.
MCFT is valuated correctly with a Price/Forward Earnings ratio of 16.02.
MCFT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MCFT is cheaper than 70.97% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MCFT to the average of the S&P500 Index (36.44), we can say MCFT is valued rather cheaply.
Industry RankSector Rank
PE 40.33
Fwd PE 16.02
MCFT Price Earnings VS Forward Price EarningsMCFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MCFT.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.01
MCFT Per share dataMCFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.64%
EPS Next 3Y7.37%

0

5. Dividend

5.1 Amount

No dividends for MCFT!.
Industry RankSector Rank
Dividend Yield N/A

MASTERCRAFT BOAT HOLDINGS IN

NASDAQ:MCFT (7/18/2025, 8:00:01 PM)

After market: 19.36 0 (0%)

19.36

-0.28 (-1.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-27 2025-08-27/bmo
Inst Owners95.07%
Inst Owner Change-0.12%
Ins Owners1.8%
Ins Owner Change3.39%
Market Cap321.57M
Analysts73.33
Price Target18.77 (-3.05%)
Short Float %7.04%
Short Ratio11.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3020.15%
Min EPS beat(2)69.69%
Max EPS beat(2)5970.61%
EPS beat(4)4
Avg EPS beat(4)1608.56%
Min EPS beat(4)69.69%
Max EPS beat(4)5970.61%
EPS beat(8)8
Avg EPS beat(8)823.77%
EPS beat(12)12
Avg EPS beat(12)554.97%
EPS beat(16)16
Avg EPS beat(16)419.55%
Revenue beat(2)1
Avg Revenue beat(2)0.82%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)2.7%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)4.73%
Revenue beat(8)7
Avg Revenue beat(8)2.49%
Revenue beat(12)10
Avg Revenue beat(12)2.19%
Revenue beat(16)10
Avg Revenue beat(16)-1.38%
PT rev (1m)0%
PT rev (3m)-18.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.36%
Valuation
Industry RankSector Rank
PE 40.33
Fwd PE 16.02
P/S 1.18
P/FCF N/A
P/OCF 60.38
P/B 1.77
P/tB 2.65
EV/EBITDA 16.01
EPS(TTM)0.48
EY2.48%
EPS(NY)1.21
Fwd EY6.24%
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.32
OCFY1.66%
SpS16.37
BVpS10.96
TBVpS7.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.55%
ROE -3.67%
ROCE 1.9%
ROIC 1.55%
ROICexc 2.36%
ROICexgc 4.53%
OM 1.35%
PM (TTM) N/A
GM 17.16%
FCFM N/A
ROA(3y)13.84%
ROA(5y)10.06%
ROE(3y)26.89%
ROE(5y)16.74%
ROIC(3y)30.44%
ROIC(5y)27.79%
ROICexc(3y)35.88%
ROICexc(5y)32.97%
ROICexgc(3y)55.34%
ROICexgc(5y)62.02%
ROCE(3y)37.33%
ROCE(5y)34.08%
ROICexcg growth 3Y-41.98%
ROICexcg growth 5Y-41.71%
ROICexc growth 3Y-36.32%
ROICexc growth 5Y-19.49%
OM growth 3Y-32.32%
OM growth 5Y-17.63%
PM growth 3Y-43.91%
PM growth 5Y-14.25%
GM growth 3Y-11.99%
GM growth 5Y-5.47%
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 104.72%
Cap/Sales 3.81%
Interest Coverage 2.43
Cash Conversion 39.29%
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.23
Altman-Z 4.42
F-Score4
WACC8.73%
ROIC/WACC0.18
Cap/Depr(3y)182.78%
Cap/Depr(5y)184.82%
Cap/Sales(3y)3.83%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.4%
EPS 3Y-29.37%
EPS 5Y-16.07%
EPS Q2Q%-18.92%
EPS Next Y-38.68%
EPS Next 2Y1.64%
EPS Next 3Y7.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.66%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.7%
Sales Q2Q%-20.63%
Revenue Next Year-24.1%
Revenue Next 2Y-6.16%
Revenue Next 3Y-3.04%
Revenue Next 5YN/A
EBIT growth 1Y-92.66%
EBIT growth 3Y-37.52%
EBIT growth 5Y-21.5%
EBIT Next Year41.13%
EBIT Next 3Y38.97%
EBIT Next 5YN/A
FCF growth 1Y-104.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-96.28%
OCF growth 3Y-43.28%
OCF growth 5Y-25.89%